Author

Tingting Chen

Chongqing Medical UniversityORCID 0000-0002-5022-4243Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Tingting Chen7 papers · University of Groningen

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Chao LiiD· 1 shared Fangzhou Lin· 1 shared Fating Yang· 1 shared Haijun YuiD· 1 shared Honghao YeiD· 1 shared Huan YangiD· 1 shared Lifeng XuiD· 1 shared Luobin Guo· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Chao LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Host Microenvironment Reprogramming by Saccharides Overcomes Lung Barriers for mRNA Therapeutics

Lifeng Xu, Tingting Chen, Chao Li, Rui Liao, Qin Xiao, Yang Chen, Fating Yang, Mingxing Luo, Mingyu Zhang, Shan Guan

This paper identifies glucose as a reprogramming agent for the airway microenvironment to enhance mRNA delivery and efficacy in lung models.

bioRxiv · Jul 14, 2025 · PreprintBioengineering

Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination

Ruijing Tang, Luobin Guo, Tingyu Wei, Tingting Chen, Huan Yang, Honghao Ye, Fangzhou Lin, Yongyi Zeng, Haijun Yu, Zhixiong Cai, Xiaolong Liu

This paper develops ePAC, a cancer vaccine using PEG10-based virus-like particles to deliver neoantigens and adjuvants, showing efficacy in preclinical models.

eLife · Jun 20, 2024Peer-reviewedCancer Biology